Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Rao V, Kalla"'
Publikováno v:
Handbook of experimental pharmacology. (193)
A selective, high-affinity A(2B) adenosine receptor (AR) antagonist will be useful as a pharmacological tool to help determine the role of the A(2B)AR in inflammatory diseases and angiogenic diseases. Based on early A(2B)AR-selective ligands with non
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fdb65317a7c638b213c633c45e265bcd
https://pubmed.ncbi.nlm.nih.gov/19639280
https://pubmed.ncbi.nlm.nih.gov/19639280
Autor:
Rao V, Kalla, Elfatih, Elzein, Thao, Perry, Xiaofen, Li, Venkata, Palle, Vaibhav, Varkhedkar, Arthur, Gimbel, Tennig, Maa, Dewan, Zeng, Jeff, Zablocki
Publikováno v:
Journal of medicinal chemistry. 49(12)
Adenosine has been suggested to induce bronchial hyperresponsiveness in asthmatics, which is believed to be an A(2B) adenosine receptor (AdoR) mediated pathway. We hypothesize that a selective, high-affinity A(2B) AdoR antagonist may provide therapeu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f3c11c4c30dcb35bb9abc8cb32f44d6f
https://pubmed.ncbi.nlm.nih.gov/16759111
https://pubmed.ncbi.nlm.nih.gov/16759111
Autor:
Elfatih Elzein, Rao V. Kalla, Xiaofen Li, Thao Perry, Art Gimbel, Dewan Zeng, David Lustig, Kwan Leung, Jeff Zablocki
Publikováno v:
Journal of Medicinal Chemistry; Mar2008, Vol. 51 Issue 7, p2267-2278, 12p
Autor:
Kalla, Rao, Zablocki, Jeff
Publikováno v:
Purinergic Signalling; Mar2009, Vol. 5 Issue 1, p21-29, 9p
Autor:
Constance N. Wilson, S. Jamal Mustafa
Since their discovery approximately 25 years ago, adenosine receptors have now emerged as important novel molecular targets in disease and drug discovery. These proteins play important roles in the entire spectrum of disease from inflammation to immu
